about
Fungal PDR transporters: Phylogeny, topology, motifs and function.Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiaeABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.Efflux-mediated antifungal drug resistance.Role of Ectopic Gene Conversion in the Evolution of a Candida krusei Pleiotropic Drug Resistance Transporter Family.Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.Identification and functional characterization of Penicillium marneffei pleiotropic drug resistance transporters ABC1 and ABC2.Mas37p, a novel receptor subunit for protein import into mitochondria.Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.Phosphorylation of candida glabrata ATP-binding cassette transporter Cdr1p regulates drug efflux activity and ATPase stability.Identification and characterization of Candida utilis multidrug efflux transporter CuCdr1p.Repression of the L-asparaginase gene during nodule development in Lupinus angustifoliusChimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function
P50
Q33624643-170DD2D3-0FA7-4606-9B50-7C508E94769FQ34293596-696CF6DD-5724-4D1D-BD08-48AD6FEF09F0Q34561878-894101ED-1293-40F5-9807-79986DED65A0Q35947069-AD8CB03F-AC37-4795-8AD2-C0FB57DEBA75Q36949532-F38A9292-5637-4F69-9AD6-48F24C250CD8Q37072109-3A304C07-BDD5-4D7E-991E-5C97CF981343Q37156645-E5E689D6-ACA0-4650-8165-47056328A8C4Q37735455-EA4EEE79-71E6-48E2-A80D-796B666FC5A9Q39207667-9493C8A7-0721-4628-A7F9-31681B3ACBC9Q39335647-FF5F990B-BA0D-4801-B1A1-B5D7461B5F14Q42138104-4DC8B696-F264-49A9-B115-25B04FCFEC91Q42653052-B6EFF65E-47DD-4AB1-942E-47B038D48DADQ45119190-DA7CBFAE-66A7-40CB-A19C-D3E22E6DDA61Q50227879-FC767DD5-7AE2-45F6-B87C-F68CF7C3FE6DQ72776116-833C1BE5-AA22-400D-BB53-7B0B735C0BCEQ84898935-178F18EA-E7AE-425A-8AB2-1E62B34D422C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Erwin Lamping
@ast
Erwin Lamping
@en
Erwin Lamping
@es
Erwin Lamping
@nl
type
label
Erwin Lamping
@ast
Erwin Lamping
@en
Erwin Lamping
@es
Erwin Lamping
@nl
prefLabel
Erwin Lamping
@ast
Erwin Lamping
@en
Erwin Lamping
@es
Erwin Lamping
@nl
P106
P1153
9232822800
P31
P496
0000-0002-4942-4782